Category Archives: T-DM1 & Systemic Treatment

T-DM1 Receives FDA Approval

On February 22, 2012, the FDA approved Kadcyla, formerly know as T-DM1, for treatment of patients with HER2 positive breast cancer. Kadcyla is new type of targeted cancer treatment known as an antibody conjugate. It combines the antibody trastuzamab (Herceptin) … Continue reading

Posted in GCD-0032, T-DM1 & Systemic Treatment, Uncategorized | 6 Comments

Started on GDC-0032

Lisa has been taking GDC-0032 since last Friday (12/14/2012) and is feeling pretty good. GDC-0032 is a new drug in the fight against cancer. It works by blocking the PIK3 protein, which helps cancer cells grow. She is receiving this … Continue reading

Posted in GCD-0032, T-DM1 & Systemic Treatment, Uncategorized | 5 Comments

Back Home and Doing OK

Just a quick update. After a one night stay at the hospital and lots of IV fluids, Lisa is back home. Yesterday afternoon she was able to eating solid food without a problem so there was no reason to keep … Continue reading

Posted in GCD-0032, T-DM1 & Systemic Treatment, Uncategorized | 6 Comments

Good-bye T-DM1, Hello GDC-0032

Seasons change and so do cancer treatments. Lisa had a good run with T-DM1, a total of nine treatments over a six-month period, but the time has come for a change. T-DM1* worked well for Lisa, however, her CT scans … Continue reading

Posted in GCD-0032, T-DM1 & Systemic Treatment, Uncategorized | 5 Comments

Clear Sailing All Summer

What a wonderful summer we had in the Great Atlantic North East! The weather was beautiful all summer. I heard some folks were talking drought, but I’m talking not having to mow the lawn. We enjoyed paddle or sail boat … Continue reading

Posted in T-DM1 & Systemic Treatment | 5 Comments

T-DM1 Infusion Number IV

I hope everyone is having a good summer and had a great 4th of July! Luckily, there is nothing much to report on Lisa’s situation. On July 6th, she had her fourth T-DM1 infusion, which she tolerated rather well. She … Continue reading

Posted in T-DM1 & Systemic Treatment | 3 Comments

T-DM1 Infusion Number III

Since Lisa’s last treatment, the drug T-DM1 has been getting a lot of positive press due to the encouraging results of the Emilia clinical trial reported at the recent meeting of the American Society for Clinical Oncology in Chicago. This … Continue reading

Posted in T-DM1 & Systemic Treatment | 5 Comments